Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.80 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | SLC18A3 | Q16572 | 1/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | CES2 | O00748 | 1/20 | 0.33 |
| ▸ | CES1 | P23141 | 1/20 | 0.33 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | NOS1 | P29475 | 1/20 | 0.32 |
| ▸ | NOS2 | P35228 | 1/20 | 0.32 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.32 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL136384 | 1.00 | — | — | |
| SCHEMBL16878797 | 1.00 | ALDH1A1 (0.80) | ALDH1A1HSD17B10SLC18A3THRBCES2 | |
| SCHEMBL434235 | 1.00 | — | — | |
| SCHEMBL9141553 | 1.00 | ALDH1A1 (0.80) | ALDH1A1HSD17B10SLC18A3THRBCES2 | |
| SCHEMBL18857303 | 1.00 | ALDH1A1 (0.80) | ALDH1A1HSD17B10SLC18A3THRBCES2 | |
| SCHEMBL7741464 | 0.95 | ALDH1A1 (0.89) | ALDH1A1HSD17B10SLC18A3THRBCES2 | |
| SCHEMBL22284064 | 0.95 | ALDH1A1 (0.89) | ALDH1A1HSD17B10SLC18A3THRBCES2 | |
| SCHEMBL11359726 | 0.95 | ALDH1A1 (0.89) | ALDH1A1HSD17B10SLC18A3THRBCES2 | |
| SCHEMBL22284066 | 0.95 | ALDH1A1 (0.89) | ALDH1A1HSD17B10SLC18A3THRBCES2 | |
| SCHEMBL21841873 | 0.95 | ALDH1A1 (0.89) | ALDH1A1HSD17B10SLC18A3THRBMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115298246-B | Vicinal diol ether derivatives of polyether polymers | P2科学公司 | 2025-05-27 | — | — | CN | disclosed |
| EP-4214269-A1 | SURFACE-COATING FLUID COMPOSITION FOR ABSORBING AND DIFFUSING VOLATILE COMPOUNDS | Ceva Santé Animale (FR) | 2023-07-26 | — | — | EP | disclosed |
| CN-110944605-B | Warming appliance | 花王株式会社 | 2023-04-18 | — | — | CN | disclosed |
| CN-110944605-B | Warming appliance | 花王株式会社 | 2023-04-18 | — | — | CN | disclosed |
| WO-2022058690-A1 | SURFACE-COATING FLUID COMPOSITION FOR ABSORBING AND DIFFUSING VOLATILE COMPOUNDS | CEVA SANTE ANIMALE (FR) | 2022-03-24 | — | — | WO | disclosed |
| US-8183395-B2 | Compositions and methods for treating cancer | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2012-05-22 | — | — | US | disclosed |
| US-8057829-B2 | Methods for repelling insects using sesquiterpene hydrocarbons and their derivatives | STERLING INTERNATIONAL INC. (US) | 2011-11-15 | — | — | US | disclosed |
| US-20100166896-A1 | METHODS FOR REPELLING INSECTS USING SESQUITERPENE HYDROCARBONS AND THEIR DERIVATIVES | STERLING INTERNATIONAL INC. (US) | 2010-07-01 | — | — | US | disclosed |
| US-20100113585-A1 | COMPOSITIONS AND METHODS FOR TREATING CANCER | RUTGERS, THE STATE UNIVERSITY (US) | 2010-05-06 | — | — | US | disclosed |
| WO-2008109717-A1 | COMPOSITIONS AND METHODS FOR TREATING CANCER | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2008-09-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100166896-A1 | METHODS FOR REPELLING INSECTS USING SESQUITERPENE HYDROCARBONS AND THEIR DERIVATIVES | CYP51A1, LSS, DAGLA | ALDH1A1 2044/4885HSD17B10 205/4885SLC18A3 1945/4885 |
| US-20100113585-A1 | COMPOSITIONS AND METHODS FOR TREATING CANCER | CASP3, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, CCAR2 | ALDH1A1 882/4885HSD17B10 1156/4885SLC18A3 4465/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.